Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 1.4 million people in the UK alone. We speak with Dr Angelo Auricchio of Boston Scientific about an innovative technology—now recommended by NICE—that could help reduce waiting lists while also addressing the associated risks of stroke and heart failure.
","author_name":"Aspect Publishing"}